Teicoplanin

This classification denotes an antibiotic with the molecular formula C58H42CL2N7O18(R1)(R2)(R3), a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4U3D3YY81M, more generally known as teicoplanin. European Medicines Agency schedules teicoplanin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04714MIG. The term TEICOPLANIN is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 37, no. 6, 1983, list 23. TEICOPLANIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule teicoplanin under HS 29419000 and SITC 54139. As of Q4 2014, TEICOPLANIN remains the US FDA Preferred Term for this commodity. Teicoplanin bears US NLM identifiers UMLS ID C0145106 and NCI Concept Code C1412. SMILES: CCCCCC=CCCC(=O)NC1C(C(C(OC1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)C(C6C(=O)NC(C7=CC(=CC(=C7C8=C(C=CC(=C8)C(C(=O)N6)NC(=O)C4NC(=O)C9C1=CC(=CC(=C1)O)OC1=C(C=CC(=C1)C(C(=O)NC(CC1=CC(=C(O3)C=C1)Cl)C(=O)N9)N)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)C(=O)O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C)Cl)CO)O)O.